OSX2:XETRA:XETRA-Ossiam US Minimum Variance ESG NR UCITS ETF 1A (EUR) EUR (EUR)

ETF | Others |

Last Closing

USD 284.8

Change

-0.50 (-0.18)%

Market Cap

USD 0.12B

Volume

2.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.09 (+0.17%)

USD 484.40B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.03 (+0.19%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.04 (-0.15%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.03 (+0.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.06 (+0.25%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+1.18 (+0.83%)

USD 98.29B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.05%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.04 (+0.09%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.34 (-0.43%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.01 (-0.02%)

USD 79.79B

ETFs Containing OSX2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.85% 77% C+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.85% 77% C+ 75% C
Trailing 12 Months  
Capital Gain 13.26% 53% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.26% 52% F 55% F
Trailing 5 Years  
Capital Gain 35.10% 57% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.10% 55% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 7.04% 59% D- 58% F
Dividend Return 7.04% 58% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.89% 60% D- 68% D+
Risk Adjusted Return 71.21% 72% C 75% C
Market Capitalization 0.12B 35% F 31% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.